See more : Citigroup Inc. (C-PK) Income Statement Analysis – Financial Results
Complete financial analysis of Brighten Optix Corporation (6747.TWO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Brighten Optix Corporation, a leading company in the Healthcare industry within the Healthcare sector.
- Jui Li Enterprise Co., Ltd. (1512.TW) Income Statement Analysis – Financial Results
- Amaroq Minerals Ltd. (AMRQ.L) Income Statement Analysis – Financial Results
- Josemaria Resources Inc. (JOSE.TO) Income Statement Analysis – Financial Results
- Terran Orbital Corporation (LLAP) Income Statement Analysis – Financial Results
- GRP Limited (GRPLTD.NS) Income Statement Analysis – Financial Results
Brighten Optix Corporation (6747.TWO)
About Brighten Optix Corporation
Brighten Optix Corporation researches and develops, manufactures, and sells specialty contact lenses in Taiwan and the Asia Pacific region. The company offers hard contact lenses under HiClear and Soclear brands; soft contact lenses under Brio+moist, iDealsoft, and MyOKvision names; contact lens care potion under the Oxy vision plus Briomoist and Mu likang brands; and other ancillary products, as well as night-wear orthokeratology hard contact lenses. Brighten Optix Corporation is based in Taipei, Taiwan.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 747.30M | 744.27M | 644.64M | 541.07M | 488.35M |
| Cost of Revenue | 244.00M | 225.38M | 215.60M | 181.79M | 164.91M |
| Gross Profit | 503.30M | 518.89M | 429.04M | 359.28M | 323.44M |
| Gross Profit Ratio | 67.35% | 69.72% | 66.55% | 66.40% | 66.23% |
| Research & Development | 110.25M | 77.55M | 36.32M | 50.72M | 53.96M |
| General & Administrative | 72.68M | 84.49M | 82.09M | 74.30M | 64.28M |
| Selling & Marketing | 112.72M | 93.93M | 83.18M | 83.93M | 76.86M |
| SG&A | 185.40M | 178.42M | 165.27M | 158.23M | 141.06M |
| Other Expenses | 0.00 | 44.26M | 75.25M | -8.06M | 0.00 |
| Operating Expenses | 295.65M | 255.98M | 201.59M | 208.95M | 195.02M |
| Cost & Expenses | 539.29M | 481.36M | 417.19M | 390.74M | 359.93M |
| Interest Income | 14.83M | 6.07M | 1.18M | 934.00K | 1.92M |
| Interest Expense | 791.00K | 487.00K | 741.00K | 1.02M | 2.38M |
| Depreciation & Amortization | 51.81M | 41.01M | 39.36M | 42.13M | 34.00M |
| EBITDA | 291.82M | 341.23M | 338.34M | 185.34M | 162.42M |
| EBITDA Ratio | 39.05% | 45.85% | 52.49% | 34.25% | 33.26% |
| Operating Income | 208.01M | 300.23M | 298.98M | 143.21M | 128.42M |
| Operating Income Ratio | 27.83% | 40.34% | 46.38% | 26.47% | 26.30% |
| Total Other Income/Expenses | 31.22M | -487.00K | -741.00K | -8.05M | 3.54M |
| Income Before Tax | 239.22M | 299.74M | 298.24M | 142.28M | 131.96M |
| Income Before Tax Ratio | 32.01% | 40.27% | 46.26% | 26.30% | 27.02% |
| Income Tax Expense | 42.13M | 45.28M | 57.82M | 17.92M | 17.08M |
| Net Income | 199.24M | 255.51M | 241.18M | 125.02M | 115.29M |
| Net Income Ratio | 26.66% | 34.33% | 37.41% | 23.11% | 23.61% |
| EPS | 8.24 | 10.56 | 10.01 | 5.68 | 5.00 |
| EPS Diluted | 8.21 | 10.52 | 9.98 | 5.66 | 4.97 |
| Weighted Avg Shares Out | 24.19M | 24.19M | 24.11M | 22.00M | 23.19M |
| Weighted Avg Shares Out (Dil) | 24.27M | 24.29M | 24.16M | 22.07M | 23.18M |
Source: https://incomestatements.info
Category: Stock Reports